| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.21 | 0.0004 |